These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 400056)

  • 1. [Pulmonary hypertension and acquired cardiopathies].
    Branzi A; Magelli C
    Torace; 1979 Mar; 22(1):84-93. PubMed ID: 400056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between telediastolic pressure and pulmonary vascular resistance in pulmonary hypertension caused by left ventricular heart disease].
    Corsini G; Castellano B; Persico S; di Girolamo D; Pette R; Salvarola G; Correale E; Tritto C
    Boll Soc Ital Cardiol; 1977; 22(12):2289-99. PubMed ID: 755505
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary hypertension in acquired valvular cardiac disease: evaluation by a scintillation camera technique.
    Krishnamurthy GT; Srinivasan NV; Blahd WH
    J Nucl Med; 1972 Aug; 13(8):604-11. PubMed ID: 5041635
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pulmonary hypertension during exercise: ready for clinical prime time?
    Maréchaux S; Ennezat PV
    Arch Cardiovasc Dis; 2011 Apr; 104(4):211-5. PubMed ID: 21624787
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary vascular disease in acquired and congenital heart disease.
    Dexter L
    Arch Intern Med; 1979 Aug; 139(8):922-8. PubMed ID: 464710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preoperative evaluation and indications for the implantation of artificial mitral valve (author's transl)].
    Waśniewska M; Pacocha W; Kapuściński O
    Przegl Lek; 1974; 31(12):986-9. PubMed ID: 4614335
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary vascular resistance.
    Harvey RM; Enson Y
    Adv Intern Med; 1969; 15():73-93. PubMed ID: 4908626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-functional significance of the radiological study of the lung in heart diseases].
    Valsecchi F
    Minerva Med; 1970 May; 61(40):2206-19. PubMed ID: 5419288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic evaluation of pulmonary hypertension secondary to mitral valve disease].
    Ruíz Ros JA; Sogorb Garrí F; Palacios Motilla V; Cebolla Rosell R; Algarra Vidal FJ
    Rev Esp Cardiol; 1975; 28(6):517-26. PubMed ID: 1215607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course of pulmonary hypertension in patients operated for rheumatic mitral heart disease].
    Privalova EV; Cherepenin LP; Ershov VI; Baloian GM; Buravikhina TA; Ermakov AI; Ivanov AS
    Ter Arkh; 2000; 72(4):58-62. PubMed ID: 10833802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of lung function and pulmonary hypertension preceding surgery of acquired heart defects].
    Ebner E; Knoth E; Riedel E
    Z Gesamte Inn Med; 1981 Nov; 36(21):814-8. PubMed ID: 7331382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired cardiovascular pathology].
    Iacono A
    Arch Monaldi Mal Torace; 1989; 44(1-3):295-300. PubMed ID: 2520578
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tricuspid dysfunction: a new physiopathologic entity. Study by means of Doppler velocimetry].
    Kalmanson D; Veyrat C; Witchitz S; Derai C; Chiche P
    Ann Cardiol Angeiol (Paris); 1972 Oct; 21(5):433-47. PubMed ID: 4658158
    [No Abstract]   [Full Text] [Related]  

  • 15. Echocardiographic detection and ambulatory monitoring of valvular heart disease.
    Raichlen JS; Brest AN
    Cardiovasc Clin; 1988; 18(3):157-91. PubMed ID: 3282663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic evaluation of pulmonary vascular resistance in patients with heart diseases].
    Palacios Motilla V; Cebolla Rosell R; Algarra Vidal FJ
    Rev Clin Esp; 1972 Sep; 126(6):515-20. PubMed ID: 4658357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of pulmonary vascular resistance calculated by various methods].
    Mariani M; Barsotti A; Balbarini A; Tartarini G; Giutini C
    Boll Soc Ital Cardiol; 1975; 20(10):1305-11. PubMed ID: 1234430
    [No Abstract]   [Full Text] [Related]  

  • 18. Valvular disease.
    Bashore TM; Khandheria B
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):7A-9A. PubMed ID: 15261682
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary pulmonary hypertension associated with mitral valve prolapse and ruptured tricuspid chordae tendineae (author's transl)].
    Kayawake S; Matsukubo H; Torii Y; Tsuji Y; Inoue D; Furukawa K; Watanabe T; Katsume H; Ijichi H
    Kokyu To Junkan; 1980 Aug; 28(8):925-9. PubMed ID: 7209148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease].
    Marozsán I; Szatmáry L; Kelemen S
    Orv Hetil; 1989 Apr; 130(18):945-8. PubMed ID: 2726244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.